Here are three things to know about the deal.
1. Teleflex develops devices for surgery, cardiac, respiratory and emergency care. Vascular Solutions offers devices for diagnostic and interventional vascular procedures.
2. Teleflex’s offer of $56 per share represents a premium of 1.6 percent on the stock’s closing value as of Thursday, according to a Reuters report.
3. The deal is expected to close in the first half of 2017.
More articles on supply chain:
How Amazon trains new warehouse workers in just 2 days
Ariad Pharma earns full FDA approval for cancer drug Iclusig
Trump picks Elaine Chao for transportation secretary: 7 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.